Marko Živin

Development of an in-vivo active reversible butyrylcholinesterase inhibitor

Urban Košak, Boris Brus, Damijan Knez et al. · Scientific Reports · 2016 · 159 citations · Full text

The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity

Urban Košak, Boris Brus, Damijan Knez et al. · Journal of Medicinal Chemistry · 2017 · 151 citations · Full text

Combinatorial Chemistry, Scopolamine Model, Neurochemical Biomarkers +23

Nephrotoxic effects of chronic administration of microcystins -LR and -YR

Aleksandra Milutinović, Marko Živin, Ruda Zorc‐Pleskovič et al. · Toxicon · 2003 · 133 citations

Renal Function, Medicine, Chronic Administration +8

Evolution of Nova-Dependent Splicing Regulation in the Brain

Nejc Jelen, Jernej Ule, Marko Živin et al. · PLoS Genetics · 2007 · 92 citations · Full text

Alternative Exons, Transcriptional Regulation, Neuroanatomy +12

Alterations in cytochrome c oxidase activity and energy metabolites in response to kainic acid-induced status epilepticus

Dejan Milatović, Marko Živin, Ramesh C. Gupta et al. · Brain Research · 2001 · 72 citations

Energy Metabolites, Neurophysiology, Medicine +10